Latest Payments News

EBR Systems has secured final CMS approval for Transitional Pass-Through reimbursement for its WiSE CRT System, effective October 1, 2025, enhancing hospital adoption prospects in the U.S.

SPDR S&P/ASX 200 ETF (STW) has announced an estimated ordinary dividend of AUD 0.836278 per security for the quarter ending 30 September 2025, with a Dividend Reinvestment Plan available to investors.

Bank of Queensland Limited announces a fully franked quarterly distribution of AUD 1.2182 per Capital Note 3 security, reflecting a 4.89% annualised yield tied to the 3-month BBSW plus margin.

Starpharma has entered a significant collaboration with Genentech to develop dendrimer-drug conjugates for oncology, securing an upfront payment and potential milestone earnings exceeding half a billion dollars.

Kalamazoo Resources has strategically expanded its Ashburton Gold Project in Western Australia by acquiring the contiguous Xanadu Gold Project and securing a new exploration licence, significantly increasing its exploration footprint amid a strong gold price environment.

Starpharma has entered a landmark collaboration with Genentech to develop innovative cancer therapies using its proprietary DEP® platform, securing $5.5 million upfront and potential milestones exceeding $560 million.

Orora Limited has confirmed its ordinary dividend for the six months ending June 2025 at 5 cents per share and announced the Dividend Reinvestment Plan price at AUD 2.0903, with payments scheduled for early October.

Cochlear Limited has updated its dividend details, confirming a fully franked ordinary dividend of AUD 2.15 per share for the first half of 2025, with payments available in multiple currencies based on shareholder location.

HealthCo Healthcare & Wellness REIT has collected all outstanding rent from Healthscope and extended a rent deferral to support the ongoing sale process, while suspending distributions to preserve liquidity.

Woolworths Group Limited has updated its dividend details, confirming a fully franked 45 cent per share payout for the first half of FY25 and setting the Dividend Reinvestment Plan price at $27.78.

Peak Rare Earths has secured court approval for its acquisition by Shenghe Resources, marking a pivotal moment with shares set to suspend and delist soon. Shareholders will receive $0.443 per share as the scheme moves toward completion.

The Supreme Court of New South Wales has approved Shenghe Resources’ acquisition scheme for Peak Rare Earths, setting the stage for a significant ownership change and share suspension on the ASX.